MTOR_MOUSE - dbPTM
MTOR_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MTOR_MOUSE
UniProt AC Q9JLN9
Protein Name Serine/threonine-protein kinase mTOR
Gene Name Mtor
Organism Mus musculus (Mouse).
Sequence Length 2549
Subcellular Localization Endoplasmic reticulum membrane
Peripheral membrane protein
Cytoplasmic side . Golgi apparatus membrane
Peripheral membrane protein
Cytoplasmic side . Mitochondrion outer membrane
Peripheral membrane protein
Cytoplasmic side . Lysosome . Cytopl
Protein Description Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals. MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor. In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1. To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A. mTORC1 also negatively regulates autophagy through phosphorylation of ULK1. Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1. Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP. mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor. Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules. As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton. Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1. mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B. mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422'. Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms. [PubMed: 19440205]
Protein Sequence MLGTGPAVATASAATSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNSTRIGRFANYLRNLLPSSDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQPNALVGLLGYSSPQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRSSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKTVQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVASITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSQGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEVPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSSQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAASGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKEDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTAHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAASAAAATSTEGSNSESEAESNENSPTPSPLQKKVTEDLSKTLLLYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRTTCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKAGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MLGTGPAV
-------CCCCCCCC
35.87-
117PhosphorylationYLRNLLPSSDPVVME
HHHHHCCCCCHHHHH
47.5524723360
230MalonylationREPKEMQKPQWYRHT
CCCHHHCCCHHHHHH
37.5526320211
230UbiquitinationREPKEMQKPQWYRHT
CCCHHHCCCHHHHHH
37.55-
243UbiquitinationHTFEEAEKGFDETLA
HHHHHHHHCCCHHHH
72.4422790023
298UbiquitinationQQQLVHDKYCKDLMG
HHHHHCHHHHHHHCC
37.3622790023
484PhosphorylationQVDATVFTCISMLAR
CCCHHHHHHHHHHHH
12.4728059163
487PhosphorylationATVFTCISMLARAMG
HHHHHHHHHHHHHHC
15.1928059163
498UbiquitinationRAMGPGIQQDIKELL
HHHCCCHHHHHHHHH
40.5927667366
536UbiquitinationPQLKKDIQDGLLKML
HHHHHHHHHHHHHHH
49.1827667366
567PhosphorylationGLAHQLASPGLTTLP
CHHHHHCCCCCCCCC
28.2626745281
571PhosphorylationQLASPGLTTLPEASD
HHCCCCCCCCCCHHH
32.0026643407
572PhosphorylationLASPGLTTLPEASDV
HCCCCCCCCCCHHHH
45.4126643407
809PhosphorylationIGELAQVSGLEMRKW
HHHHHHHCCCCHHHH
26.1123737553
858PhosphorylationTGYVVEPYRKYPTLL
CCCCCCCHHHCHHHH
13.2621454597
861PhosphorylationVVEPYRKYPTLLEVL
CCCCHHHCHHHHHHH
7.76-
880PhosphorylationKTEQNQGTRREAIRV
HHHCCCCCHHHHHHH
19.45-
898UbiquitinationLGALDPYKHKVNIGM
HHHCCCCCCCCCEEC
42.1922790023
900UbiquitinationALDPYKHKVNIGMID
HCCCCCCCCCEECCC
32.5922790023
1162PhosphorylationIIHPIVRTLDQSPEL
HHHHHHHCCCCCHHH
24.6429895711
1166PhosphorylationIVRTLDQSPELRSTA
HHHCCCCCHHHHHHH
21.7329895711
1218AcetylationVLICRIVKGYTLADE
EEEEEEECCCCCCCC
43.7723806337
1218UbiquitinationVLICRIVKGYTLADE
EEEEEEECCCCCCCC
43.7727667366
1218MalonylationVLICRIVKGYTLADE
EEEEEEECCCCCCCC
43.7726320211
1239PhosphorylationYQHRMLRSSQGDALA
HHHHHHHHCCCCHHH
24.0529472430
1240PhosphorylationQHRMLRSSQGDALAS
HHHHHHHCCCCHHHC
31.5829472430
1247PhosphorylationSQGDALASGPVETGP
CCCCHHHCCCCCCCC
44.4729472430
1256UbiquitinationPVETGPMKKLHVSTI
CCCCCCCCEEEEEEE
56.1522790023
1257UbiquitinationVETGPMKKLHVSTIN
CCCCCCCEEEEEEEE
37.2622790023
1261PhosphorylationPMKKLHVSTINLQKA
CCCEEEEEEEEHHHH
16.9025521595
1262PhosphorylationMKKLHVSTINLQKAW
CCEEEEEEEEHHHHH
16.8827818261
1293UbiquitinationRLSLELLKDSSSPSL
HHHHHHHCCCCCHHH
69.0922790023
1400UbiquitinationYAKALHYKELEFQKG
HHHHHCHHHHCCCCC
45.1122790023
1406UbiquitinationYKELEFQKGPTPAIL
HHHHCCCCCCCHHHH
72.6522790023
1415PhosphorylationPTPAILESLISINNK
CCHHHHHHHHHCCCC
27.7921743459
1418PhosphorylationAILESLISINNKLQQ
HHHHHHHHCCCCCCC
25.2621743459
1430PhosphorylationLQQPEAASGVLEYAM
CCCHHHHHHHHHHHH
36.16-
1465UbiquitinationDALVAYDKKMDTNKE
HHHHHHHHCCCCCCC
37.0022790023
1471UbiquitinationDKKMDTNKEDPELML
HHCCCCCCCCHHHHH
66.6322790023
1511UbiquitinationVNDETQAKMARMAAA
CCHHHHHHHHHHHHH
24.2322790023
1650UbiquitinationVVSPHEDMRTWLKYA
CCCCCHHHHHHHHHH
3.6127667366
1655UbiquitinationEDMRTWLKYASLCGK
HHHHHHHHHHHHCCH
30.2722790023
1821PhosphorylationKKKLRHASGANITNA
HHHHHHHCCCCCCCH
32.1125293948
1826PhosphorylationHASGANITNATTAAT
HHCCCCCCCHHHHHH
20.7125293948
1829PhosphorylationGANITNATTAATTAA
CCCCCCHHHHHHHHH
21.0225293948
1830PhosphorylationANITNATTAATTAAS
CCCCCHHHHHHHHHH
16.3425293948
1833PhosphorylationTNATTAATTAASAAA
CCHHHHHHHHHHHHH
17.9525293948
1834PhosphorylationNATTAATTAASAAAA
CHHHHHHHHHHHHHH
18.5925293948
1837PhosphorylationTAATTAASAAAATST
HHHHHHHHHHHHHCC
18.9025293948
1842PhosphorylationAASAAAATSTEGSNS
HHHHHHHHCCCCCCC
31.3025293948
1843PhosphorylationASAAAATSTEGSNSE
HHHHHHHCCCCCCCH
21.5325293948
1844PhosphorylationSAAAATSTEGSNSES
HHHHHHCCCCCCCHH
39.7625293948
1847PhosphorylationAATSTEGSNSESEAE
HHHCCCCCCCHHHHH
30.8319060867
1849PhosphorylationTSTEGSNSESEAESN
HCCCCCCCHHHHHCC
44.1725293948
1851PhosphorylationTEGSNSESEAESNEN
CCCCCCHHHHHCCCC
41.7619060867
1855PhosphorylationNSESEAESNENSPTP
CCHHHHHCCCCCCCC
57.3925293948
1859PhosphorylationEAESNENSPTPSPLQ
HHHCCCCCCCCCHHH
24.7925293948
1861PhosphorylationESNENSPTPSPLQKK
HCCCCCCCCCHHHHH
35.9025293948
1893PhosphorylationQGFFRSISLSRGNNL
HHHHHHHCCCCCCCH
22.8722006019
2066UbiquitinationERGPQTLKETSFNQA
HHCCCCHHHCCHHHH
63.4322790023
2069PhosphorylationPQTLKETSFNQAYGR
CCCHHHCCHHHHHCH
24.2423684622
2159PhosphorylationRIQSIAPSLQVITSK
EEECCCCCCEEECCC
23.55-
2164PhosphorylationAPSLQVITSKQRPRK
CCCCEEECCCCCCCE
30.89-
2173PhosphorylationKQRPRKLTLMGSNGH
CCCCCEEEEECCCCC
20.10-
2370UbiquitinationEVAMTREKFPEKIPF
HHHHCCCCCCCCCCH
64.0322790023
2442PhosphorylationNTKGNKRSRTRTDSY
CCCCCCCCCCCCCCC
39.3422322096
2444PhosphorylationKGNKRSRTRTDSYSA
CCCCCCCCCCCCCCC
38.8825619855
2446PhosphorylationNKRSRTRTDSYSAGQ
CCCCCCCCCCCCCCC
28.7825619855
2448PhosphorylationRSRTRTDSYSAGQSV
CCCCCCCCCCCCCCE
22.0019643477
2449PhosphorylationSRTRTDSYSAGQSVE
CCCCCCCCCCCCCEE
12.8325619855
2450PhosphorylationRTRTDSYSAGQSVEI
CCCCCCCCCCCCEEE
29.8525619855
2454PhosphorylationDSYSAGQSVEILDGV
CCCCCCCCEEECCCC
22.3122322096
2473PhosphorylationPAHKKAGTTVPESIH
CCHHHCCCCCCHHHH
29.4926824392
2474PhosphorylationAHKKAGTTVPESIHS
CHHHCCCCCCHHHHH
32.9027087446
2478PhosphorylationAGTTVPESIHSFIGD
CCCCCCHHHHHHHCC
21.3825521595
2481PhosphorylationTVPESIHSFIGDGLV
CCCHHHHHHHCCCCC
19.5220138985
2496UbiquitinationKPEALNKKAIQIINR
CHHHCCHHHHHHHHH
50.0422790023

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
2173TPhosphorylationKinaseAKT1P31750
Uniprot
2446TPhosphorylationKinasePRKAA1Q13131
GPS
2446TPhosphorylationKinaseRPS6KB1Q8BSK8
Uniprot
2446TPhosphorylationKinaseAMPK-FAMILY-GPS
2446TPhosphorylationKinaseAMPK_GROUP-PhosphoELM
2448SPhosphorylationKinaseRPS6KB1Q8BSK8
Uniprot
2481SPhosphorylationKinaseMTORQ9JLN9
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
1261SPhosphorylation

19487463
2159SPhosphorylation

19487463
2164TPhosphorylation

19487463
2173TPhosphorylation

19487463

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MTOR_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FKB1A_HUMANFKBP1Aphysical
9334222
RICTR_MOUSERictorphysical
20801936
IKKA_MOUSEChukphysical
22351927
LST8_HUMANMLST8physical
18235224
RPTOR_HUMANRPTORphysical
18235224
DDB1_HUMANDDB1physical
18235224
RICTR_HUMANRICTORphysical
18235224
KS6B1_MOUSERps6kb1physical
17386266
RICTR_MOUSERictorphysical
18664580
RICTR_MOUSERictorphysical
18851840
LST8_MOUSEMlst8physical
18851840
MLXIP_MOUSEMlxipphysical
25332233

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MTOR_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Site-specific mTOR phosphorylation promotes mTORC1-mediated signalingand cell growth.";
Acosta-Jaquez H.A., Keller J.A., Foster K.G., Ekim B., Soliman G.A.,Feener E.P., Ballif B.A., Fingar D.C.;
Mol. Cell. Biol. 29:4308-4324(2009).
Cited for: PHOSPHORYLATION AT SER-1261, AND ENZYME REGULATION.
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry.";
Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.;
J. Proteome Res. 7:5314-5326(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2481, AND MASSSPECTROMETRY.
"Large-scale phosphorylation analysis of mouse liver.";
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2478 AND SER-2481, ANDMASS SPECTROMETRY.

TOP